Travere Therapeutics, Inc. · NASDAQ:TVTX
Heerma Peter sold 7,215 Travere Therapeutics, Inc. shares (Form 4)
Traded Apr 13 to Apr 14, 2026 · Filed Apr 15, 2026
From Apr 13 to Apr 14, 2026, Heerma Peter (CHIEF COMMERCIAL OFFICER) sold 7,215 Travere Therapeutics, Inc. shares at US$41.93 for US$303K, leaving 138,608 shares. Filed Apr 15, 2026 (Form 4).
- Sold
- 7,215 shares
- Price
- US$41.93
- Value
- US$303K
- Holding after
- 138,608 shares
- Trading plan
- No
- Role
- CHIEF COMMERCIAL OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 13, 2026 | Common Stock | Award | 14,000 | 145,823 | Direct | |
| Apr 14, 2026 | Common Stock | Sale | 7,215 | US$41.93 | 138,608 | Direct |
Source
Related
- Travere Therapeutics, Inc.
- Heerma Peter
- Travere Therapeutics, Inc. shareholders
- Form 4 · Heerma Peter · Sep 17, 2026
- Form 4 · Heerma Peter · May 6, 2026
- Form 4 · Dube Eric M · Oct 19, 2026
- Form 4 · Dube Eric M · Sep 17, 2026
- Form 4 · Rote William E. · Sep 17, 2026
- Form 4 · Inrig Jula · Sep 17, 2026
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026